Research

In close cooperation with other Institutes of the MHH, we deal with a spectrum of different cell types as a therapeutic option for malignant and neurodegenerative diseases.

T-cells

  • CD20-CAR T cells
    Publications (1, 2, 3)
  • GD2-CAR T cells (TRUCKs)
    Publication
  • Regulatory T cells (Tregs)
    Clinical Department of Haematology, Haemostaseology, Oncology and Stem Cell Transplantation, MHH

NK cells

  • CAR NK cells - Clinical Department of Haematology, Haemostaseology, Oncology and Stem Cell Transplantation, MHH (Prof. M. Scherr)

Induced pluripotent stem cells (iPSC)

  • iPSC-derived macrophages - Institute of Experimental Haematology, MHH (Prof. T. Moritz, Prof. N. Lachmann)

Mesenchymal stromal cells(MSC)

  • MSC from the bone marrow - Clinical Department of Neurology and Clinical Neurophysiology, MHH (Prof. S. Petri)

Dendritic Zcells

  • Induced, genetically modified dendritic cells as vaccines(iDCtWT1) - Clinical Department of Haematology, Haemostaseology, Oncology and Stem Cell Transplantation, MHH

Publications